Royalty Pharma (RPRX) Payout Ratio (2019 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Payout Ratio (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.06 Bn | 133.21 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn |
| 4 | Moderna | 57.22 Bn | 52.08 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.59 Bn | 44.59 Bn | - |
| 6 | BeOne Medicines | 40.43 Bn | 35.33 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.17 Bn | 27.34 Bn | - |
| 9 | Insmed | 27.60 Bn | 26.43 Bn | 358.27 Mn |
| 10 | Incyte | 25.73 Bn | 21.19 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42 |
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.42 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | -7.49 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.25 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | -4.29 |
| Sep 30, 2021 | 0.57 |